During the last session, Tempest Therapeutics Inc (NASDAQ:TPST)’s traded shares were 0.47 million, with the beta value of the company hitting -2.45. At the end of the trading day, the stock’s price was $0.84, reflecting an intraday gain of 0.43% or $0.01. The 52-week high for the TPST share is $6.00, that puts it down -614.29 from that peak though still a striking 16.67% gain since the share price plummeted to a 52-week low of $0.70. The company’s market capitalization is $36.48M, and the average trade volume was 1.21 million shares over the past three months.

Tempest Therapeutics Inc (TPST) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. TPST has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.25.

Tempest Therapeutics Inc (NASDAQ:TPST) trade information

Tempest Therapeutics Inc (TPST) registered a 0.43% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 0.43% in intraday trading to $0.84, hitting a weekly high. The stock’s 5-day price performance is 3.26%, and it has moved by -10.66% in 30 days. Based on these gigs, the overall price performance for the year is -73.63%.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 62.66%. While earnings are projected to return 29.54% in 2025, the next five years will return 12.39% per annum.

TPST Dividends

Tempest Therapeutics Inc is due to release its next quarterly earnings in April. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

The next largest institutional holding, with 0.43 million shares, is of FMR LLC’s that is approximately 1.9426% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $0.95 million.

Also, the Mutual Funds coming in first place with the largest holdings of Tempest Therapeutics Inc (TPST) shares are Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund . Data provided on Dec 31, 2024 indicates that Fidelity Extended Market Index Fund owns about 226.2 shares. This amounts to just over 0.52 percent of the company’s overall shares, with a $0.19 million market value. The same data shows that the other fund manager holds slightly less at 174.01, or about 0.40% of the stock, which is worth about $0.15 million.